Rare Diseases
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
News
Two rare neurologic conditions linked to COVID-19
Two variants of Guillain-Barré syndrome—Miller Fisher syndrome and polyneuritis cranialis—have been linked with COVID-19 infection.
From the Journals
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
News
First case of COVID-19 presenting as Guillain-Barré reported
A case report from China suggests a possible association between GBS and SARS-CoV-2 infection.
From the Journals
Accelerated fetal growth in boys associated with development of AML
The correlation was seen especially in infant boys and those with minimally differentiated leukemia.
Conference Coverage
Merkel cell carcinoma management undergoes revolution
LAHAINA, HAWAII – “There are really important prognostic and therapeutic implications for a baseline scan in almost any patient with early Merkel...
Conference Coverage
SCC survival remains poor in epidermolysis bullosa
LONDON – Median survival was 2.4 years in patients with generalized severe recessive dystrophic epidermolysis bullosa after a first diagnosis.
Article
Presentation of a Rare Malignancy: Leiomyosarcoma of the Prostate
Prostatic leiomyosarcoma is an aggressive malignancy with a high risk of metastasis and a poor prognosis that poses unique diagnostic and...
Conference Coverage
Deferiprone noninferior to deferoxamine for iron overload in SCD, rare anemias
An oral iron chelator granted accelerated approval for thalassemia is noninferior to deferoxamine for iron overload in patients with sickle cell...